CYP2C9 Gene Variants, Drug Dose, and Bleeding Risk in Warfarin-Treated Patients: A HuGEnet™ Systematic Review and Meta-Analysis
Genetics in Medicine - United States
doi 10.1097/01.gim.0000153664.65759.cf
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2005
Authors
Publisher
Springer Science and Business Media LLC